Internal Medicine, Medical Oncology · Tuscaloosa, AL
NPI
1033137518
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
809 University Blvd E, Dch Cancer Treatment Center
Tuscaloosa, AL, 35401
Phone (205) 759-7803
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
837 services
Medicare patients, 2024
178
Average age 75
Drug cost, 2024
$2.0M
881 prescriptions
Company payments, 2025
$644
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John W Dubay was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 229 times for 107 patients. In total John W Dubay billed 837 services in 13 codes, and Medicare paid $43K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-01.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 229 | 107 | $11.81 | $2,705 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 159 | 64 | $11.31 | $1,798 |
| 99214 Office E&M - Established | Facility | 114 | 65 | $61.76 | $7,040 |
| 99215 Office E&M - Established | Facility | 107 | 60 | $105.15 | $11K |
| 99215 Office E&M - Established | Office | 84 | 46 | $102.65 | $8,622 |
| 99214 Office E&M - Established | Office | 77 | 37 | $58.45 | $4,500 |
| 99205 Office E&M - New | Facility | 30 | 30 | $118.64 | $3,559 |
By year: 2022 $30K for 370 services; 2023 $39K for 480 services; 2024 $43K for 837 services.
Medicare prescription drug claims, 2024
In 2024, the drug John W Dubay prescribed most often to Medicare patients was Prednisone, with 72 prescriptions and refills. In total John W Dubay wrote 881 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 72 | 79 | 26 | $271 |
| Abiraterone Acetate Generic | 59 | 60 | 16 | $144K |
| Oxycodone Hcl Generic | 56 | 56 | 23 | $1,059 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 54 | 54 | 13 | $776 |
| Levothyroxine Sodium Generic | 34 | 66 | 11 | $462 |
| Tagrisso Osimertinib Mesylate | 29 | 29 | Under 11 | $465K |
| Hydrocortisone Generic | 28 | 30 | Under 11 | $957 |
| Gabapentin Generic | 26 | 26 | Under 11 | $155 |
| Fentanyl Generic | 24 | 24 | Under 11 | $3,482 |
| Dexamethasone Generic | 20 | 20 | 18 | $378 |
| Tramadol Hcl Generic | 19 | 19 | Under 11 | $191 |
| Ondansetron Hcl Generic | 17 | 17 | Under 11 | $283 |
| Ondansetron Odt Ondansetron | 17 | 17 | Under 11 | $545 |
| Lanreotide Acetate Generic | 14 | 14 | Under 11 | $123K |
| Xtandi Enzalutamide | 13 | 13 | Under 11 | $175K |
Brand drugs: 197 claims; generic drugs: 684 claims; opioid claims: 180.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John W Dubay $644 ($644 in general payments such as food, travel and fees) from 10 companies. The largest payer was Delcath Systems with $235.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.